BOTOX® contains onabotulinumtoxinA, a purified botulinum neurotoxin type A complex supplied as a sterile, vacuum dried powder for solution for injection. This formulation contains 200 Allergan Units per vial together with human serum albumin and sodium chloride. Canadian BOTOX is available in 50, 100, and 200 Unit vial strengths.
OnabotulinumtoxinA functions as a neuromuscular blocking agent. At targeted nerve endings, botulinum toxin type A inhibits the release of the neurotransmitter acetylcholine, temporarily reducing the nerve signalling responsible for muscle contraction. The resulting decrease in muscle activity is reversible over time as neuromuscular signalling gradually recovers.
This mechanism allows BOTOX to be used therapeutically in conditions characterized by excessive or involuntary muscle activity. Canadian prescribing information includes uses involving focal spasticity, cervical dystonia, blepharospasm, strabismus, chronic migraine, hyperhidrosis, and certain forms of urinary incontinence and overactive bladder, depending on the patient and indication.
For chronic migraine, BOTOX is used prophylactically in qualifying adults and is believed to interfere with pain related signaling involved in migraine development. For hyperhidrosis, its local action blocks nerve signals that stimulate sweat glands, reducing excessive sweat production. In bladder applications, onabotulinumtoxinA reduces uncontrolled contraction of the bladder muscle.
This product provides:
- Active Ingredient: OnabotulinumtoxinA
- Strength: 200 Allergan Units per vial
- Format: Sterile vacuum dried powder for solution for injection
- Brand: BOTOX®
- Manufacturer/Brand Origin: Allergan
- Product Type: Prescription botulinum toxin type A
A technical distinction is important when listing this product: BOTOX potency is expressed in Allergan Units, not conventional International Units (IU). BOTOX Units are specific to the manufacturer’s biological assay and cannot be directly converted to or substituted for the units used by other botulinum toxin products. For that reason, “BOTOX 200 Units” is more technically accurate product page wording than “BOTOX 200 IU.”
BOTOX is a prescription injectable that must be administered by an appropriately qualified and experienced healthcare professional. Correct patient selection, anatomical knowledge, product preparation, and administration are important to its safe use.
One of the most important warnings associated with botulinum toxin products is the potential for distant spread of toxin effect beyond the treated area. This can produce generalized muscle weakness, difficulty swallowing, speech problems, or breathing difficulties, which can become life threatening in severe cases. Anyone experiencing swallowing or respiratory difficulty following treatment requires immediate medical assessment.
Other adverse effects vary according to the area and condition being treated and can include local muscle weakness, injection site discomfort, eyelid drooping, headache, neck discomfort, urinary effects, and allergic reactions. Individuals with certain neuromuscular disorders or infection at the proposed treatment site may not be appropriate candidates for BOTOX treatment.
The 200 Unit vial is a professional use prescription product and should be handled, stored, prepared, and administered according to the current BOTOX product monograph and by an appropriately qualified healthcare professional.
